SCHEMBL25912293

SCHEMBL25912293

CCc1nc2nc3ccccn3c2n1-c1c(C)cccc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.41
MAPT P10636 4/20 0.39
ALDH1A1 P00352 7/20 0.39
GAA P10253 6/20 0.39
KDM4E B2RXH2 5/20 0.39
HSD17B10 Q99714 2/20 0.39
NPC1 O15118 1/20 0.39
GLA P06280 1/20 0.39
HPGD P15428 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
KMT2A Q03164 4/20 0.38
MAPK1 P28482 2/20 0.38
MEN1 O00255 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19229381 0.84 GAA (0.42) DPP4MAPTALDH1A1GAAKDM4E
SCHEMBL25913069 0.71 MAPK1 (0.39) DPP4MAPTALDH1A1GAAKDM4E
SCHEMBL19229378 0.71 GAA (0.58) DPP4MAPTALDH1A1GAAKDM4E
SCHEMBL19234005 0.70 DPP4 (0.40) DPP4MAPTALDH1A1GAAKDM4E
SCHEMBL19234003 0.70 DPP4 (0.40) DPP4MAPTALDH1A1GAAKDM4E
SCHEMBL13266746 0.70 KDM4E (0.65) MAPTALDH1A1GAAKDM4EHSD17B10
SCHEMBL19234006 0.67 GAA (0.44) DPP4MAPTALDH1A1GAAKDM4E
SCHEMBL19234002 0.67 GAA (0.44) DPP4MAPTALDH1A1GAAKDM4E
SCHEMBL25912253 0.67 ALDH1A1 (0.35) MAPTALDH1A1GAAKDM4EHSD17B10
SCHEMBL2759541 0.65 ALDH1A1 (0.53) DPP4MAPTALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11716898-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11716898-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, JUND DPP4 4512/4885MAPT 48/4885ALDH1A1 2423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.